CXCR4 and prostate carcinoma: Since the overexpression of miR-21 and/or CXCR4 is also observed in many other cancers, such as ovarian, gastric, colonic, pancreatic, breast, and prostate cancers [9, 54], our study could also shed some light on the efficacious treatment development for them.